Polymorphisms in genes related to folate and cobalamin metabolism and the associations with complex birth defects

Prenatal Diagnosis - Tập 28 Số 6 - Trang 485-493 - 2008
Raf Brouns1, N. T. C. Ursem2, Jan Lindemans1, Wim C.J. Hop3, Saskia M.F. Pluijm4, Eric A.P. Steegers2, Régine P.M. Steegers‐Theunissen5,3,2,6
1Department of Clinical Chemistry, Erasmus MC University Medical Center, Rotterdam, The Netherlands
2Department of Obstetrics and Gynaecology, Division of Obstetrics and Prenatal Medicine, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
3Department of Epidemiology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
4Department of Public Health, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
5Department of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, The Netherlands
6Department of Paediatrics, Division of Paediatric Cardiology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands

Tóm tắt

AbstractObjectiveTo investigate the associations between biomarkers and genetic variants involved in homocysteine metabolism and the risk of complex birth defects.MethodsTotal homocysteine (tHcy), folate, cobalamin, apo‐transcobalamin (apo‐TC) and apo‐haptocorrin (apo‐HC) were measured in the amniotic fluid of 82 women who were pregnant with a child having a complex birth defect, such as neural tube defect, cleft lip and/or palate, heart defect or omphalocele, and in 110 women pregnant with a non‐malformed child. The determined genotypes of the child comprised of 5, 10‐methylenetetrahydrofolate reductase (MTHFR 677C > T, 1298A > C), methionine synthase (MTR 2756A > G), methionine synthase reductase (MTRR 66A > G) and transcobalamin (TCN2 776C > G). Univariate and multivariate logistic regression analyses were performed.ResultsSignificantly lower cobalamin and higher apo‐TC, apo‐HC, tHcy and folate concentrations were determined in amniotic fluids of cases compared with controls (p⩽0.001). Logistic regression analysis revealed that after adjustment for maternal age, children carrying the MTHFR 677T allele showed a four‐fold increased risk of having a complex birth defect, OR (95% CI) = 4.0 (1.1–15.4). Other genotypes did not show significant associations.ConclusionThe MTHFR 677C > T polymorphism in conjunction with reduced folate‐ and/or cobalamin status may increase the risk of complex birth defects. Copyright © 2008 John Wiley & Sons, Ltd.

Từ khóa


Tài liệu tham khảo

10.1038/sj.ejhg.5200830

10.1073/pnas.95.22.13217

Bianchi DW, 2001, Large amounts of cell‐free fetal DNA are present in amniotic fluid, Clin Chem, 47, 1867, 10.1093/clinchem/47.10.1867

10.1016/j.cardiores.2004.07.010

10.1002/ajmg.c.30004

10.1002/(SICI)1096-8628(19990521)84:2<151::AID-AJMG12>3.0.CO;2-T

10.1055/s-2007-993887

10.1056/NEJMoa067103

10.1038/ng0595-111

10.1111/j.1399-0004.1988.tb03478.x

10.1016/S0378-3782(02)00040-3

Grossowicz N, 1983, Vitamin B12‐binding proteins in human amniotic fluid: an index to fetal maturity, Am J Obstet Gynecol, 146, 331, 10.1016/0002-9378(83)90756-1

10.1016/S0304-3940(03)00468-3

10.1136/jmg.2005.032656

10.1086/513520

Jacob E, 1975, Measurement of unsaturated “”granulocyte‐related” (TC I and TC III) and “”liver‐related” (TC II) B12 binders by instant batch separation using a microfine precipitate of silica (QUSO G32), J Lab Clin Med, 86, 505

10.1016/S0022-3476(99)70102-2

10.1093/hmg/5.12.1867

10.1073/pnas.95.6.3059

10.1093/clinchem/48.9.1383

10.1111/j.1399-0004.1986.tb00590.x

10.1016/S0140-6736(95)90165-5

10.1002/(SICI)1096-8628(19990903)86:1<71::AID-AJMG14>3.0.CO;2-Y

10.1016/0140-6736(91)90133-A

10.1093/jn/137.8.1863

10.1111/j.1471-0528.2007.01528.x

10.1111/j.1447-0756.1993.tb00393.x

10.1373/clinchem.2005.057810

10.1074/jbc.M103707200

10.1016/S0022-3476(98)70526-8

Pfeiffer CM, 1999, Rapid and accurate HPLC assay for plasma total homocysteine and cysteine in a clinical laboratory setting, Clin Chem, 45, 290, 10.1093/clinchem/45.2.290

10.1182/blood.V62.1.234.234

10.1073/pnas.93.26.15227

10.1002/(SICI)1096-8628(19981116)80:3<196::AID-AJMG2>3.0.CO;2-V

10.1056/NEJM199101173240315

10.1097/01.AOG.0000129955.47943.2a

10.1016/0028-2243(90)90212-J

10.1016/0002-9378(95)90474-3

10.1002/(SICI)1097-0223(199806)18:6<545::AID-PD293>3.0.CO;2-2

10.1093/qjmed/90.2.111

10.1016/S0140-6736(95)91743-8

10.1086/301825

10.1111/j.1471-0528.2006.01109.x

10.1093/ajcn/81.6.1436

10.1006/mgme.1998.2714

10.1136/bmj.39079.618287.0B

10.1006/mgme.1999.2879

10.1002/(SICI)1096-9926(199911)60:5<253::AID-TERA4>3.0.CO;2-V